These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37389231)

  • 21. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of puncturing different portal vein branch during transjugular intrahepatic portosystemic shunt with 8 mm covered stent: a propensity-score analysis.
    Zhou Y; Ma J; Ju S; Zhang Z; Zhang W; Yang M; Zhou X; Yan Z; Luo J
    Eur J Gastroenterol Hepatol; 2021 Aug; 33(8):1110-1116. PubMed ID: 33741800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
    Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
    Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
    Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
    Xia Y; Tie J; Wang G; Zhuge Y; Wu H; Xue H; Xu J; Zhang F; Zhao L; Huang G; Zhang M; Wei B; Li P; Wu W; Chen C; Tang C; Zhang C
    Hepatol Int; 2023 Aug; 17(4):967-978. PubMed ID: 36807252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
    Liu J; Shi Q; Xiao S; Zhou C; Zhou B; Yuan F; Zheng C; Lin S; Qian K; Feng G; Xiong B
    J Gastroenterol Hepatol; 2020 Feb; 35(2):278-283. PubMed ID: 31222830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic venous pressure gradient and rebleeding risk of patients with nonalcoholic steatohepatitis cirrhosis after variceal bleeding.
    Shi Y; Shen W; Xu G; Wang X; Ning B
    Front Med (Lausanne); 2023; 10():1224506. PubMed ID: 37564045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
    Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
    Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children.
    Lv Y; He C; Guo W; Yin Z; Wang J; Zhang B; Meng X; Cai J; Luo B; Wu F; Niu J; Fan D; Han G
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):233-41. PubMed ID: 26381818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding.
    Ma L; Liu Y; Yan Z; Zhang W; Zhang Z; Yang M; Yu J; Zhou X; Chen S; Wang J; Ma J; Luo J
    J Gastroenterol; 2023 May; 58(5):494-502. PubMed ID: 36892638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.
    Silva-Junior G; Turon F; Baiges A; Cerda E; García-Criado Á; Blasi A; Torres F; Hernandez-Gea V; Bosch J; Garcia-Pagan JC
    Gastroenterology; 2017 May; 152(6):1358-1365. PubMed ID: 28130066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding.
    Zhou J; Wu Z; Wu J; Wang X; Li Y; Wang M; Yang Z; Peng B; Zhou Z
    Surg Endosc; 2013 Aug; 27(8):2712-20. PubMed ID: 23392981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.